Vissiennon Cica, Hammoud Dima, Rodewald Steffen, Fester Karin, Goos Karl-Heinz, Nieber Karen, Arnhold Jürgen
University of Leipzig, Medical Faculty, Institute of Medical Physics and Biophysics, Leipzig.
REPHA GmbH Biologische Arzneimittel, Langenhagen.
Planta Med. 2017 Jul;83(10):846-854. doi: 10.1055/s-0043-104391. Epub 2017 Mar 6.
A traditional herbal medicinal product, containing myrrh, chamomile flower, and coffee charcoal, has been used in Germany for the relief of gastrointestinal complaints for decades. Clinical studies suggest its use in the maintenance therapy of inflammatory bowel disease. However, the pharmacological mechanisms underlying the clinical effects are not yet fully understood.The present study aims to elucidate immunopharmacological activities of myrrh, chamomile flower, and coffee charcoal by studying the influence of each plant extract on gene expression and protein release of activated human macrophages.The plant extracts effect on gene and protein expression of activated human monocyte-derived macrophages was investigated by microarray gene expression analysis and assessment of the release of pro- and anti-inflammatory mediators (TNF, chemokine CXCL13, and interleukin-10) using an ELISA test system.The extracts of myrrh, chamomile flower, and coffee charcoal influenced gene expression of activated human macrophages within the cytokine/chemokine signaling pathway. Particularly, chemokine gene expression was suppressed. Subsequently, the production of CXCL13 and, to a minor extent, cytokine TNF was inhibited by all herbal extracts. Chamomile flower and coffee charcoal extracts enhanced interleukin-10 release from activated macrophages. The observed effects on protein release were comparable to the effect of budesonide, which decreased TNF and CXCL13 and enhanced interleukin-10 release.The components of the herbal medicinal product influence the activity of activated human macrophages on both gene and protein level. The induced alterations within chemokine/cytokine signaling could contribute to a positive effect on the immunological homeostasis, which is disturbed in patients with chronic intestinal inflammation.
一种传统草药产品,含有没药、洋甘菊花和咖啡炭,在德国已用于缓解胃肠道不适数十年。临床研究表明其可用于炎症性肠病的维持治疗。然而,其临床效果背后的药理机制尚未完全明确。本研究旨在通过研究每种植物提取物对活化的人巨噬细胞基因表达和蛋白质释放的影响,阐明没药、洋甘菊花和咖啡炭的免疫药理活性。通过微阵列基因表达分析以及使用酶联免疫吸附测定(ELISA)测试系统评估促炎和抗炎介质(肿瘤坏死因子(TNF)、趋化因子CXCL13和白细胞介素-10)的释放,研究了植物提取物对活化的人单核细胞衍生巨噬细胞基因和蛋白质表达的影响。没药、洋甘菊花和咖啡炭的提取物影响了细胞因子/趋化因子信号通路中活化的人巨噬细胞的基因表达。特别是,趋化因子基因表达受到抑制。随后,所有草药提取物均抑制了CXCL13的产生,在较小程度上也抑制了细胞因子TNF的产生。洋甘菊花和咖啡炭提取物增强了活化巨噬细胞中白细胞介素-10的释放。观察到的对蛋白质释放的影响与布地奈德的作用相当,布地奈德可降低TNF和CXCL13并增强白细胞介素-10的释放。该草药产品的成分在基因和蛋白质水平上均影响活化的人巨噬细胞的活性。趋化因子/细胞因子信号传导中诱导的变化可能有助于对免疫稳态产生积极影响,而慢性肠道炎症患者的免疫稳态受到破坏。